Cavan Ventures Welcomes Dr. Manju Sharma, MD and Doctor of Naturopathy, to Board

Life Science Investing News

Cavan Ventures Inc. (TSXV:CVN) has appointed Dr. Manju Sharma, MD and Doctor of Naturopathy, to its advisory board.

Cavan Ventures Inc. (TSXV:CVN) has appointed Dr. Manju Sharma, MD and Doctor of Naturopathy, to its advisory board. The appointment is a key part of Cavan’s efforts to accelerate the diversification of its growth plan into the medical marijuana and hemp industry.

As quoted in the press release:

Dr. Manju Sharma is a medical doctor, working currently as a scientist at Vancouver Prostate Centre, Vancouver General Hospital for the last 5 years. Prior to this she worked in the department of Pathology and Lab Medicine, VGH for 10 years on various projects including molecular diagnosis of tuberculosis, multi-drug resistant tuberculosis, human solid tumors, kidney disorders, medicinal herbal plants like Echinacea which is widely used all over Europe and North America for the treatment of cough and cold: active principles and their mode of action on various human viral and bacterial diseases. She has published over 70 papers in medical journals and has made several presentations in the field of Medicine.

Click here to read the full Cavan Ventures Inc. (TSXV:CVN) press release.

The Conversation (0)
×